John R. Keyserlingk M.D., M.Sc., F.R.C.S.(C), F.A.C.S.
Medical Director, Surgical Oncologist
Dr. John R. Keyserlingk, completed his specialty training in both General Surgery and Otolaryngology at McGill, and a Fellowship in Surgical Oncology at the Royal Marsden Hospital in London. He is currently Assistant Professor of Surgery at McGill University and a member of the Department of Surgery at the Université de Montréal. He is a staff surgeon in the Divisions of General surgery, Surgical Oncology and Otolaryngology at St. Mary’s Hospital, the Department of Surgery at the Sacré-Coeur Hospital, the Division of General Surgery at the Montreal General Hospital and previously at the Department of Otolaryngology at the Royal Victoria Hospital. He is a Fellow of a number of societies including the Royal College of Physicians and Surgeons of Canada, the American College of Surgeons, the American Society of Head and Neck Surgeons, the American Society of Clinical Oncology and the American Society of Breast Surgeons.
Dr. Keyserlingk is the founder and currently the Medical Director of the Ville Marie Medical and Women’s Health Center (VM Medical) which includes the VM Medical Multidisciplinary Breast and Oncology Centers, the VM Medical Integrative Health and Wellness Center and the on-site VM Medical MRI / Radiology, PET-CT & Nuclear Imaging Centers. He is assisted by a team of physicians and radiologists who work with an on-site team of surgical, medical and radiation oncologists, as well as an interdisciplinary team of psychologists, genetic counsellors, kinesiologists and nutritionists. Together their mission is to optimize breast cancer prevention and early detection.
Dr. Keyserlingk also sits on the Board of the National Consortium of Breast Centers (NCBC), which is composed of over 800 Breast Centers across the world, of which the VM Medical Breast Center is the first Canadian NCBC member. He also chairs the NCBC International Committee. He has taken a strong public stand on the rights of patients to have dignified access to the best technology available, and both published and presented on issues regarding breast cancer prevention and early detection.